St. Jude Children's Research Hospital

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Established: 1962-01-01

Employees: -

Market Cap: -

Website: http://www.stjude.org/

Clinical Trials

Safety and Efficacy of Cyclophosphamide, Sorafenib, Bevacizumab, and Atezolizumab in Pediatric Solid Tumor Patients

Phase 1

Recruiting

Conditions: Refractory Solid Tumor
Hepatocellular Carcinoma
Malignant Solid Tumor
Pediatric Cancer
Pediatric Solid Tumor
Fibrolamellar Carcinoma

Interventions: Drug: Atezolizumab
Drug: Sorafenib
Drug: Bevacizumab
Drug: Cyclophosphamide

First Posted Date: 2022-07-21

Last Posted Date: 2023-12-22

Lead Sponsor: St. Jude Children's Research Hospital

Target Recruit Count: 64

Registration Number: NCT05468359

Locations: 🇺🇸
St. Jude Children's Research Hospital, Memphis, Tennessee, United States

The Decision To Enroll In Therapeutic Clinical Trials In A Pediatric Cancer Clinical Network

Recruiting

Conditions: Knowledge, Attitudes, Practice

First Posted Date: 2022-07-12

Last Posted Date: 2024-11-22

Lead Sponsor: St. Jude Children's Research Hospital

Target Recruit Count: 500

Registration Number: NCT05454618

Locations: 🇺🇸
St. Jude Children's Research Hospital, Memphis, Tennessee, United States

Exploring The Role Of Palliative Care In Phase 1 Enrolled Pediatric Oncology Patients

Recruiting

Conditions: Quality of Life

First Posted Date: 2022-06-09

Last Posted Date: 2024-12-11

Lead Sponsor: St. Jude Children's Research Hospital

Target Recruit Count: 40

Registration Number: NCT05412563

Locations: 🇺🇸
St. Jude Children's Research Hospital, Memphis, Tennessee, United States
🇺🇸
National Cancer Institute/National Institutes of Health, Bethesda, Maryland, United States

Response to Influenza Vaccination in Pediatric Oncology Patients

Recruiting

Conditions: Pediatric Cancer
Transplant-Related Cancer
Hematologic Malignancy

First Posted Date: 2022-05-20

Last Posted Date: 2024-10-08

Lead Sponsor: St. Jude Children's Research Hospital

Target Recruit Count: 113

Registration Number: NCT05384288

Locations: 🇺🇸
St. Jude Children's Research Hospital, Memphis, Tennessee, United States

Patient- Generated Health Data to Predict Childhood Cancer Survivorship Outcomes

Recruiting

Conditions: Survivorship
Childhood Cancer

First Posted Date: 2022-04-22

Last Posted Date: 2024-10-23

Lead Sponsor: St. Jude Children's Research Hospital

Target Recruit Count: 620

Registration Number: NCT05342155

Locations: 🇺🇸
St. Jude Children's Research Hospital, Memphis, Tennessee, United States

Trial Treating Relapsed Acute Lymphoblastic Leukemia With Venetoclax and Navitoclax

Phase 1

Active, not recruiting

Conditions: Refractory Acute Lymphoblastic Leukemia
Relapsed Acute Lymphoblastic Leukemia

Interventions: Drug: Venetoclax
Drug: Navitoclax
Drug: Dexamethasone
Drug: Vincristine
Drug: Calaspargase Pegol
Drug: Dasatinib
Drug: Leucovorin
Drug: Cytarabine
Drug: Intrathecal Triples
Biological: Blinatumomab
Drug: Pegaspargase
Drug: Methotrexate
Drug: Erwinia asparaginase
Drug: Mercaptopurine
Drug: Cyclophosphamide
Drug: Etoposide
Radiation: Radiation

First Posted Date: 2022-01-14

Last Posted Date: 2024-11-26

Lead Sponsor: St. Jude Children's Research Hospital

Target Recruit Count: 35

Registration Number: NCT05192889

Locations: 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States
🇺🇸
St. Jude Children's Research Hospital, Memphis, Tennessee, United States

Evaluating Immune Response to COVID-19 Vaccines in Patients With Cancer, Transplant or Cellular Therapy Recipients

Active, not recruiting

Conditions: Cancer
Solid Tumor Malignancy
Cellular Therapy
Transplant-Related Cancer
Hematologic Malignancy
Hematopoietic System--Cancer
Solid Organ Transplant
Hematopoietic Cell Transplant

First Posted Date: 2021-12-20

Last Posted Date: 2024-10-08

Lead Sponsor: St. Jude Children's Research Hospital

Target Recruit Count: 21

Registration Number: NCT05164016

Locations: 🇺🇸
Le Bonheur, Memphis, Tennessee, United States
🇺🇸
LeBonheur, Memphis, Tennessee, United States
🇺🇸
St. Jude Children's Research Hospital, Memphis, Tennessee, United States

Cardiac Autonomic Dysfunction in Childhood Cancer Survivors

Suspended

Conditions: Childhood Cancer
Autonomic Dysfunction

First Posted Date: 2021-11-24

Last Posted Date: 2024-05-31

Lead Sponsor: St. Jude Children's Research Hospital

Target Recruit Count: 6000

Registration Number: NCT05132673

Locations: 🇺🇸
St. Jude Children's Research Hospital, Memphis, Tennessee, United States

Quantitative Assessment of Radiation-induced Neuroinflammation - A Proof of Principle Study

Phase 2

Active, not recruiting

Conditions: Brain Tumor
Medulloblastoma

Interventions: Drug: [18F]DPA714

First Posted Date: 2021-11-22

Last Posted Date: 2024-08-20

Lead Sponsor: St. Jude Children's Research Hospital

Target Recruit Count: 22

Registration Number: NCT05128903

Locations: 🇺🇸
St.Jude Children's Research Hospital, Memphis, Tennessee, United States

Revealing Information Genuinely & Honestly Across Time: Pediatric Oncology Stakeholder Preferences and Recommendations for Prognostic Communication

Completed

Conditions: Communication
Pediatric Cancer

First Posted Date: 2021-11-11

Last Posted Date: 2024-10-21

Lead Sponsor: St. Jude Children's Research Hospital

Target Recruit Count: 95

Registration Number: NCT05116566

Locations: 🇺🇸
St. Jude Children's Research Hospital, Memphis, Tennessee, United States

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy